Astrocytoma epidemiology and demographics

Jump to navigation Jump to search

Astrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Astrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Study

Case #1

Astrocytoma epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Astrocytoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Astrocytoma epidemiology and demographics

CDC on Astrocytoma epidemiology and demographics

Astrocytoma epidemiology and demographics in the news

Blogs on Astrocytoma epidemiology and demographics

Directions to Hospitals Treating Astrocytoma

Risk calculators and risk factors for Astrocytoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

In year 2012 the number of new cases of brain and other nervous system cancer was 6.4 per 100,000 men and women per year in United States. The number of deaths was 4.3 per 100,000 men and women per year based on 2008-2012 deaths. Patients of all age groups may develop astrocytoma. Pilocytic astrocytoma accounting for between 0.6-5.1% of all intracranial neoplasms.

Epidemiology and Demographics

  • Pilocytic astrocytoma accounting for between 0.6-5.1% of all intracranial neoplasms (1.7-7% of all glial tumors) are the most common primary brain tumor of childhood, accounting for 70-85% of all cerebellar astrocytomas.[1]
  • Less than 10% of Glioblastoma Multiforme form more slowly following degeneration of low-grade astrocytoma or anaplastic astrocytoma. These are called secondary GBM and are more common in younger patients (mean age 45 versus 62 years).

Prevalence

Incidence

  • The incidence of astrocytoma is 0.23 per 100,000 and the number of new cases 700 per year

Age

  • People can develop astrocytomas at any age.
  • The low-grade type is more often found in children or young adults, while the high-grade type are more prevalent in adults.
  • Subependymal giant cell tumors are a well known manifestation of TS, affecting 5-15% of patients with the condition. They are principally diagnosed in patients under 20 years of age, but are occasionally found in older people[2].
  • Anaplastic astrocytomas occur in adulthood with peak incidence between 40 and 50 years of age, which is older than low grade astrocytomas and younger than glioblastoma.[3]
  • Pilocytic astrocytomas are tumors of young people, with 75% occurring in the first two decades of life, typically late in the first decade (9-10 years). There is no recognised gender predisposition.[2]

Mortality

  • The number of deaths was 4.3 per 100,000 men and women per year based on 2008-2012 deaths.

References

  1. "Surveillance, Epidemiology, and End Results Program".
  2. 2.0 2.1 "Subependymal giant cell astrocytoma [Dr Bruno Di Muzio and Dr Jeremy Jones]".
  3. Atlas, Scott (2009). Magnetic resonance imaging of the brain and spine. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. ISBN 078176985X.

Template:Nervous tissue tumors de:Astrozytom nl:Astrocytoom

Template:WikiDoc Sources